Albert Bourla: 2025 was a very good year for Pfizer Inc. I'm very pleased with strong execution to deliver and, frankly, overdeliver on our financial commitments. If successful, we will substantially ...

The following is an update to the fourth quarter 2025 outlook and gives an overview of our current expectations for the fourth quarter. Outlooks presented may vary from the actual fourth quarter 2025 ...

After 22 wonderful years, I’ve decided to take the exciting and terrifying step of leaving in order to try to build something ...

The Chemicals & Products segment adjusted earnings is expected to be below break-even in Q4’25. Trading & Optimisation is expected to be significantly lower than Q3’25. Following the completion of the ...

(MENAFN- GlobeNewsWire - Nasdaq) The following is an update to the fourth quarter 2025 outlook and gives an overview of our current expectations for the fourth quarter. Outlooks presented may vary ...

The following is an update to the fourth quarter 2025 outlook and gives an overview of our current expectations for the fourth quarter. Outlooks presented may vary from the actual fourth quarter 2025 ...

I. Is it the Central Office? C. 0. Of course it is. What do you want ? I. Will you switch me on to the Bagleys, please ? C. 0. All right. Just keep your ear to the telephone. Then I heard, k-look, ...

Johnson Outdoors Inc. designs, manufactures, and markets seasonal and outdoor recreation products for fishing worldwide. It operates through Fishing; Camping & Watercraft Recreation; and Diving ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

The AHRQ systematic review included 48 RCTs and two retrospective cohort studies. Lung cancer and mesothelioma were the most commonly addressed types of cancer. Nonpharmacologic interventions such as ...